Explore the Global Oncolytic Virus Cancer Therapy Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Oncolytic Virus Cancer Therapy Market

Key Insight

Oncolytic virus cancer therapy sales will grow through 2036, led by solid tumor indications at a 31.2% share, supported by an expanding clinical trial pipeline for melanoma and glioblastoma. Herpes simplex virus holds a 22.5% share. The market is set to reach USD 44.8 million by 2026-end and USD 314.3 million by 2036.

May 02, 2026

Anurag Sharma

286 Pages

Cite this Report

Oncolytic Virus Cancer Therapy Market

https://www.futuremarketinsights.com/reports/oncolytic-virus-cancer-therapy-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Amgen
DNAtrix
GeneThera Inc
Oncolytics Biotech Inc
PsiOxus Therapeutics Ltd
Replimune Group Inc
Sorrento Therapeutics
TILT Biotherapeutics
Transgene SA
Vyriad

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncolytic Virus Cancer Therapy Market

Key Players

Similar Industry Reports